In the fourth quarter 2025 Regencell Bioscience Holdings Limited did not have Long Term Debt.

Within Legal Cannabis industry Regencell Bioscience Holdings Limited achieved the lowest Long Term Debt to Equity in the fourth quarter 2025. While total ranking remained the same in the fourth quarter 2025 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debts RGC´s has?
What are RGC´s Equity?

Select the Comparisons :

None ▼

Select the Ratio:

Long Term Debt to Equity ▼

None ▼

Long Term Debt to Equity ▼

RGC Long Term Debt to Equity	(Jun 30 2025) Q4	0 Q3	0 Q2	0 Q1	(Jun 30 2023) Q4
Y / Y Equity Change	-59.46 %	-59.46 %	-59.46 %	-59.46 %	-29.81 %
Y / Y Long Term Debt Change	-	-	-	-	-
Long Term Debt to Equity MRQ	-	-	-	-	-
RGC's Total Ranking	#	#	#	#	#
Seq. Equity Change	0 %	0 %	0 %	-59.46 %	0 %
Seq. Long Term Debt Change	-	-	-	-	-

New: More RGC's historic Long Term Debt to Equity Ratios >>

Long Term Debt to Equity fourth quarter 2025 Company Ranking
Within:	No.
Legal Cannabis Industry	#
Consumer Non Cyclical Sector	#
Overall Market	#

Long Term Debt to Equity Statistics
High	Average	Low
0	0	0

Financial Statements
Regencell Bioscience Holdings Limited's Equity	$ 5 Millions	Visit RGC's Balance sheet
Regencell Bioscience Holdings Limited's Long Term Debt	$ 0 Millions	Visit RGC's Balance sheet
Source of RGC's Sales		Visit RGC's Sales by Geography

Cumulative Regencell Bioscience Holdings Limited's Long Term Debt to Equity

RGC's Long Term Debt to Equity for the trailling 12 Months

RGC Long Term Debt to Equity	(Jun 30 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Jun 30 2023) 12 Months
Y / Y Equity TTM Growth	-59.46 %	-49.91 %	-42.04 %	-35.43 %	-29.81 %
Y / Y Long Term Debt TTM Growth	-	-	-	-	-
Long Term Debt to Equity TTM	-	-	-	-	-
Total Ranking TTM
Seq. Equity TTM Growth	-26.83 %	-21.16 %	-17.46 %	-14.87 %	-9.6 %
Seq. Long Term Debt TTM Growth	-	-	-	-	-

RGC Company Profile >> Back to RGC Financial Strength Comparisons >> Compare RGC Debt to Equity Ratio to its Competitors

On the trailing twelve months basis During the twelve months ending Q4 2025 Regencell Bioscience Holdings Limited did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Legal Cannabis industry RGC recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debts RGC´s has?
What are RGC´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within:	No.
Within the Legal Cannabis Industry	#
Consumer Non Cyclical Sector	#
Within the Market	#

trailing twelve months Long Term Debt to Equity Statistics
High	Average	Low
0	0	0

Companies with similar Long Term Debt to Equity in the quarter ending Jun 30 2025, within Legal Cannabis Industry

Long Term Debt to Equity

Jun 30 2025 MRQ Long Term Debt

Jun 30 2025 MRQ Equity

Date modified: 2025-11-01T05:56:14+00:00

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

Regencell Bioscience Holdings Limited's Long Term Debt to Equity

Cumulative Regencell Bioscience Holdings Limited's Long Term Debt to Equity

RGC Long Term Debt to Equity